Michael Way was an undergraduate in the Biophysics Department at King's College, University of London. During his PhD he studied the actin binding properties of gelsolinin the laboratory of Alan Weeds in the structural studies division of the Medical Research Council Laboratory of Molecular Biology, Cambridge, UK.

In 1989 he received the Max Perutz Student Prize for his PhD work. He remained in Alan's lab as a postdoc for three years, studying the actin binding properties of alpha-actinin, dystrophin and gelsolin, before moving to Boston for a second three-year postdoc with Paul Matsudaira at the Whitehead Institute, Massachusetts Institute of Technology, USA.

In 1995, he moved back to Europe to start a research group analysing how vaccinia virus hijacks the actin cytoskeleton to enhance its spread in the Cell Biology Programme at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany. In 2001, Michael returned to London to head the cell motility group in the London Research Institute, Cancer Research UK (now part of the Francis Crick Institute).

His group uses a variety of quantitative imaging and biochemical approaches to study how Vaccinia virus takes advantage of its host as a model system to understand signalling networks, cytoplasmic transport, cytoskeletal dynamics and cell migration. Outside the context of vaccinia infection, he also investigates the cellular function of actin related proteins (Arps) and Tes, a tumour suppressor that negatively regulates Mena-dependent cell migration.

Michael has been an editor for the Journal of Cell Science since 2005 and was appointed its editor-in-chief in 2012. He is also on the editorial boards of Cellular Microbiology, Cell Host and Microbe, Developmental Cell, EMBO Journal, EMBO Reports and Small GTPases. He was elected an EMBO member in 2006 and a fellow of the Academy of Medical Sciences in 2015.

Michael is also an honorary Professor at UCL (University College London) as well as King's College London and, since October 2013, has also been a Professor of Virology at Imperial College London.

Qualifications and history

1988
MRC Laboratory of Molecular Biology, Cambridge, UK
PhD in Structural Studies
1989
MRC Laboratory of Molecular Biology, Cambridge, UK
Postdoctoral Fellow
1992
Whitehead Institute, MIT, USA
Postdoctoral Fellow
1995
EMBL-Heidelberg, Germany
Group Leader, Cell Biology Programme
2001
Imperial Cancer Research Fund, London, UK (now Cancer Research UK)
Group Leader
2015
Francis Crick Institute
Group Leader
Displaying 1 - 20 of 74
Last updated : 17 April 2021 03:09